Applicability of Three Alternative Instruments for Food Authenticity Analysis: GMO Identification by Burrell, A. et al.
SAGE-Hindawi Access to Research
Biotechnology Research International
Volume 2011, Article ID 838232, 8 pages
doi:10.4061/2011/838232
Research Article
Applicabilityof ThreeAlternative Instrumentsfor
Food Authenticity Analysis: GMO Identiﬁcation
A.Burrell,C.Foy, andM.Burns
Molecular and Cell Biology, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK
Correspondence should be addressed to M. Burns, malcolm.burns@lgc.co.uk
Received 6 July 2010; Revised 22 November 2010; Accepted 19 December 2010
Academic Editor: Yves Bertheau
Copyright © 2011 A. Burrell et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ensuring foods are correctly labelled for ingredients derived from genetically modiﬁed organisms (GMOs) is an issue facing
manufacturers, retailers, and enforcement agencies. DNA approaches for the determination of food authenticitys often use
the polymerase chain reaction (PCR), and PCR products can be detected using capillary or gel electrophoresis. This study
examines the ﬁtness for purpose of the application of three laboratory electrophoresis instruments (Agilent Bioanalyzer 2100,
Lab901 TapeStation, and Shimadzu MCE-202 MultiNA) for the detection of GMOs using PCR based on a previously validated
protocol. Whilst minor diﬀerences in the performance characteristics of bias and precision were observed, all three instruments
demonstrated their applicability in using this protocol for screening of GMO ingredients.
1.Introduction
T h eg l o b a lf o o di n d u s t ryf a c e sv a r i o u sc h a l l e n g e si nt e r m so f
providing conﬁdence in the authenticity of foods. Ensuring
foods are correctly labelled for presence and levels of speciﬁc
ingredients, occurrence of GMOs, and preventing expensive
food ingredients being fraudulently replaced with inferior
ones, are some of the many issues facing UK industry,
Trading Standards, and Public Analysts.
DNA approaches for the determination of food authen-
ticity are becoming increasingly common and easy to
implement. These DNA approaches complement results
from a number of other analytical approaches (e.g., pro-
teins, chemical analysis, isotope ratios, nuclear magnetic
resonance spectroscopy, and Infrared spectroscopy) and are
also applicable in instances where protein assays are not
considered ﬁt for purpose, for example, when analysing
highly processed foods [1]. Use of end-point polymerase
chain reaction (PCR) is an eﬀective, cost-eﬃcient DNA
approach for determination of food authenticity [2].
Since the digitalisation of electrophoresis, the Agilent
Bioanalyzer 2100 has become a well characterised and
established instrument, commonly used within the food
analysissectorbyUKPublicAnalysts(PAs)whoactonbehalf
of the local government for enforcement and legislative
purposes. Many DNA detection and screening protocols that
utilise end-point PCR and have been applied on the Agilent
Bioanalyzer 2100 have been validated and endorsed by the
UK Food Standards Agency (FSA). The Agilent Bioanalyzer
2100 has been shown to be useful as a screening approach
in a number of food authenticity studies [3]a n dc a no ﬀer
an alternative approach compared to instruments using the
“gold standard” of real-time PCR, that can be prohibitively
expensive to purchase in terms of initial ﬁnancial outlay and
costs associated with maintenance and expertise.
A multiplex PCR screening protocol for the qualitative
detection of DNA from GMOs has been characterised exten-
sively [4]. This protocol was tested across ten independent
laboratories as part of a blind interlaboratory trial and
performance characteristics, including precision, speciﬁcity,
sensitivity, and associated false positive and negative rates
e v a l u a t e d .T h eﬁ t n e s sf o rp u r p o s eo ft h i sp r o t o c o lw a s
validated and demonstrated using the Agilent Bioanalyzer
[5].
Recently, several alternative electrophoresis instruments
have emerged onto the market, reporting very similar or
improved performance, increased range of applications, or
greater cost eﬃciency compared to the Agilent Bioanalyzer2 Biotechnology Research International
2100 [6, 7]. Examples of alternative electrophoresis instru-
ments include the range of Applied Biosystems capillary
electrophoresis instruments (e.g., the ABI PRISM 3100
Genetic Analyzer, the Beckman Coulter GenomeLab GeXP
Genetic Analysis System, the Caliper LabChipGXII, the
Lab901 TapeStation, the QIAGEN QIAxcel System, and the
Shimadzu MCE-202 MultiNA). The applicability of using
the multiplex PCR screening protocol for detection of GMO
ingredients [4] on these alternative electrophoresis instru-
ments has not previously been reported or characterised.
Demonstratingtheapplicationofaprotocolforthedetection
of GMO ingredients across a range of electrophoresis
machines would increase the scope and potential choice of
instruments available for the food authenticity sector.
The aim of this study was to perform a comparative
analysis of three electrophoresis instruments, with respect
to their ﬁtness for purpose in using a previously vali-
dated multiplex PCR screening protocol for the qualitative
detection of DNA from GMOs. The Agilent Bioanalyzer
2100, Lab901 TapeStation, and the Shimadzu MCE-202
MultiNA were selected as a representative cross section of
electrophoresis instruments available. DNA proﬁles from
these three instruments were compared objectively, and
estimation of the performance characteristics of bias and
precision made. The applicability of all three instruments
in successfully applying the previously validated protocol
for screening of GMO ingredients was demonstrated, and
these may provide alternative choices for those laboratories
involved in food analysis which do not always have access to
real-time PCR.
2.MaterialsandMethods
2.1. “GMO Multiplex Screen” Protocol. The FSA protocol
for genetically modiﬁed organism (GMO) detection “GMO
multiplex screen protocol: Standard operating procedure for the
simultaneous detection of general DNA targets associated with
the presence of genetically modiﬁed soya and maize” [4]w a s
used, hereafter referred to as the “GMO multiplex screen”
protocol. Standard end-point PCR was conducted following
the “GMO multiplex screen” protocol, which was designed
to be a simple, cost-eﬀective protocol for screening food
ingredients, animal feed, and some processed foods. It is
a qualitative multiplex end-point PCR approach allowing
simultaneous detection of wild-type and GM soya and
maize and cauliﬂower mosaic virus (CaMV). The protocol
allowed DNA amplicons representing Zein (maize reference
gene), Lectin (soya reference gene), cauliﬂower mosaic
virus (CaMV viral DNA), and NOS terminator/CaMV 35s
promoter (control genes indicative of genetic modiﬁcation)
to be generated. The assay included the CaMV target, that
does not crossreact with the 35S gene, to allow samples
that contained GMO ingredients to be diﬀerentiated from
samples that contained material from cruciferous plants that
had been naturally infected by the CaMV virus [4]. The
“GMO multiplex screen” protocol, optimised and validated
for use on the Agilent Bioanalyzer 2100, has not been
extensively tested on alternative electrophoresis instruments.
2.2.DNASamples. Asetoftestsamplesandpositive controls
were provided as part of the validation of “GMO multiplex
screen” trial for Public Analysts during 2008. DNA was
extracted using a modiﬁed CTAB method [8], resuspended
i nw a t e r ,a n ds t o r e da t−20◦C.
Two control materials and six blind test samples were
evaluated as part of the current study. The test samples con-
sisted of maize ﬂour (contained 0.1% Bt11 maize); spice mix
( C a M Va n dt r a c el e v e l so fm a i z e ) ;t e x t u r e dv e g e t a b l ep r o t e i n
(3% Roundup Ready soya and trace levels of maize); maize
ﬂour (1% Bt11 maize); maize polenta (no GM); and animal
feed(3%RoundupReadysoyaandtracelevelsofmaize).The
ﬁrst positive control consisted of 0.5% GM soya and CaMV
DNA. The second positive control contained approximately
1ngofDNAextractedfrom5%w/wRoundupReadysoya
certiﬁed reference material [9], 1ng of DNA from a 5%
w/w NK603 maize certiﬁed reference material [10], and an
authenticated, but unspeciﬁed, amount of DNA from CaMV.
This second positive control produced all bands (Zein,
Lectin, CaMV, and the NOS terminator/CaMV 35s promoter
complex) when used in end-point PCR at a ﬁnal amount
of 20ng DNA per reaction [4]. The DNA concentration in
each sample was quantiﬁed and diluted to ﬁnal amounts
corresponding to approximately 20 or 100ng per reaction
for end-point PCR. Sterile nuclease-free water was used as
an appropriate negative control for extraction purposes.
2.3. PCR. The PCR consisted of a multiplex assay containing
ﬁve assays detecting CaMV, CaMV 35s promoter, NOS
terminator, Lectin, and Zein amplicons. Primer sequences
were as detailed in the original protocol [4]. Each reaction
contained either 20ng or 100ng DNA, 1x QIAGEN Multi-
plex PCR Mastermix, primer master mix solution at 100nM
per primer, and the remaining reaction volume was made
up to 15μL with sterile water, as per the original protocol
[4]. Cycling conditions were as follows: 95◦C for 15mins,
40 cycles of 95◦C, 25sec; 62◦C, 30sec; 72◦C, 45sec; then
7min at 72 ◦C and held at 4◦C. The PCR was performed
on an MJ Research PTC-225 Thermal Cycler (GRI LabCare,
Rayne, UK). Samples were analysed based on the proprietary
software associated with each of the three electrophoresis
instruments, using the most appropriate kit available for
detection of PCR products between 50bp and 200bp.
2.4. Instruments
2.4.1. Agilent Bioanalyzer 2100. The Agilent 2100 Bioan-
alyzer (Agilent Technologies, Santa Clara, California) is a
capillaryelectrophoresis-basedsystemthatcananalyseDNA,
RNA, and proteins. It has a sample throughput of 12 samples
per run, and results are generated in approximately 30
minutes [11]. Capillary electrophoresis is used to separate
DNA fragments based upon size and charge. PCR products
are sized accurately and quantiﬁed by alignment with DNA
fragments from a ladder.
PCR products were analysed using the DNA 1000
LabChips on the Agilent Bioanalyzer 2100. All chips wereBiotechnology Research International 3
run as per the manufacturer’s instructions provided with
the DNA 1000 LabChip kit [11]. Fresh gel-dye matrix was
prepared with 20μl of the dye concentrate and 400μlo f
the gel matrix; the mixture was ﬁltered through a spin ﬁlter
and used in the LabChip. 5μl of the DNA marker reagent
was added to each sample well, 1μl DNA ladder reagent
was added to the assigned ladder well, and 1μl sample was
added to the corresponding sample wells. The LabChip was
vortexed and run on the Agilent Bioanalyzer 2100 using the
Expert 2100 software.
2.4.2. Lab901 TapeStation. The Lab901 TapeStation (Lab901
Limited, Loanhead, United Kingdom) is an automated gel
electrophoresis system and can facilitate the analysis of
protein, RNA, and DNA. The ScreenTape consist of 16
individual separation channels preloaded with reagents. The
instrument used in this study utilised the reusable Screen-
Tape system for the analysis of 16 samples simultaneously
within one run, but depending on the sample format
between1and96samplescanbeanalysedontheinstrument.
PCR products were analysed using the DNA 800 Tape
kit on the Lab901 TapeStation. All tapes were run as per
the manufacturer’s instructions provided with the DNA 800
Tapes [12]. Samples were loaded into 0.2ml × 8 connected
PCR tubes; 5μl neat DNA ladder was added to the ﬁrst
tube, then 4μl Loading Buﬀer and 1μl of sample were added
to each subsequent tube. Lids were placed on the 0.2ml
tubes, andthe samples werebrieﬂy vortexed andcentrifuged.
The tubes, recommended tips, and Tape were placed in
the Lab901 TapeStation and ran using the TapeStation
Controller Software GeneTools.
2.4.3. Shimadzu MCE-202 MultiNA. The Shimadzu MCE-
202 MultiNA (Shimadzu Corporation, Kyoto, Japan) uses
microchip technology to facilitate capillary electrophoresis
for nucleic acid analysis. This instrument demonstrated a
high sample throughput and can use 8 or 12 strip tubes or
96 well plate formats. PCR products were analysed using
the DNA 500 kit on the Shimadzu MCE-202 MultiNA. All
sample runs were performed by the manufacturer. Samples
were run with the reagents from the DNA 500 kit: separation
buﬀer, DNA marker reagent, and 25bp DNA ladder. The
samples were placed into the MultiNA instrument alongside
the reagents. The samples and reagents were mixed auto-
matically on-chip and ran using the MultiNA Control and
MultiNA Viewer software [13].
2.4.4. Experimental Design. Two replicate runs per instru-
ment were conducted, and two positive controls were
implemented within each chip/tape per replicate run, in
order to estimate the within and between run repeatability
associatedwithPCRampliconsizes.Duetospaceconstraints
on the chips/tapes, the complete set of test samples had to be
divided across two chips/tapes per run for both the Agilent
Bioanalyzer 2100 and the Lab901 TapeStation instruments.
However, all samples could be accommodated within one
Shimadzu MultiNA chip, so each of the duplicate runs on
this instrument consisted of just one chip. Consequently,
the Agilent Bioanalyzer 2100 and Lab901 TapeStation exper-
iments were represented by eight replicates of the positive
control (four per duplicate run), and the Shimadzu MultiNA
experiment was represented by four replicates of the positive
control (two per duplicate run).
3. Results and Discussion
3.1. “GMO Multiplex Screen” Protocol. The “GMO multiplex
screen” protocol is a qualitative multiplex end-point PCR
approach that allows simultaneous detection of wild-type
and GM soya and maize and Cauliﬂower Mosaic Virus
(CaMV) in food samples. The protocol has been evalu-
ated extensively on the Agilent Bioanalyzer [5] but has
not been tested comprehensively on other electrophoresis
instruments.
The “GMO multiplex screen” PCR contains ﬁve primer
pairs that produce amplicons from the following DNA
targets: the maize zein gene, soya lectin gene, CaMV, NOS
terminator, and CaMV 35s promoter. Primer sets for the
zein, lectin, NOS terminator, and CaMV 35S promoter
were selected from the British Standard (BS EN ISO)
21569:2005 and previously published papers. The CaMV
primer pair was designed as part of the original study [5]t o
only amplify DNA from the naturally occurring cauliﬂower
mosaic virus, and not to amplify DNA from the CaMV
35S promoter sequence used for genetic transformation.
Speciﬁcity was tested theoretically (based on available data-
base information) and conﬁrmed in the laboratory against
DNA extracted from a range of cereals and common food
ingredients with no reported false positives [5].
As part of the original study [5], all primers pairs were
tested against dilutions from appropriate certiﬁed reference
materials containing GM ingredients. Estimated limits of
detection for the lectin and zein targets, and the 35S and
NOS targets, corresponded approximately to less than 20
and less than 10 genome equivalents, respectively. Previously
the “GMO multiplex screen” has been applied to a range
of textured vegetable protein and animal feed samples from
GeMMA proﬁciency test rounds and commercially available
animal feed samples, containing between 0.5% and 3%
w/w GM maize and soya ingredients. The screening assay
successfullydetectedGMingredientsinallofthepositivetest
samples analysed, and no false negatives were reported.
As part of this original study, the “GMO multiplex
screen” protocol was evaluated further by a blind interlab-
oratory trial involving ten independent laboratories. Two
positive control materials and six blind test samples were
evaluated as part of the trial. All samples were run at
two dilution levels (corresponding to approximately 20 and
100ng of DNA per reaction) in duplicate using PCR and
visualised on the Agilent Bioanalyzer. Negative controls were
includedasnotemplatecontrols(waterreplacingDNAinthe
PCR wells) and extraction blanks. The trial organisers did
not report any conﬁrmed false positive responses from the
ten laboratories as part of this trial, further conﬁrming the
speciﬁcity of the assay. As part of this trial, 100% (nine out of
nine) of the results obtained showed that 0.5% w/w GM soya4 Biotechnology Research International
Table 1: Amplicon sizes associated with the “GMO Multiplex Screen” protocol. Amplicons sizes are shown in bp. “Theoretical size (bp)”
refers to the calculated number of base pairs in the amplicon based on available DNA sequence information. The ﬁnal three columns refer to
the average bp sizes of the amplicons as determined by the Agilent Bioanalyzer 2100, Lab901 TapeStation, and Shimadzu MultiNA, for the
positive control used in this study. Note that the NOS terminator and CaMV 35s promoter PCR products were seen as one peak on all three
instruments.
Primer set Theoretical size
(bp)
Agilent Bioanalyzer 2100 sizes
(bp)
Lab901 TapeStation sizes
(bp)
Shimadzu MultiNA sizes
(bp)
Zein 68 80 71 77
Lectin 80 90 81 86
CaMV 104 108 104 108
NOS terminator 118
131 120 127
CaMV 35S promoter 123
was detected repeatably in the ﬁrst positive control. Eight
of nine laboratories that reported results were able to detect
the 0.1% w/w Bt11 maize ﬂour test sample. This conﬁrmed
the sensitivity of the assay and suggested that the limit of
detection was between 0.5% and 0.1% w/w GM soya/maize
of a particular ingredient. The original study stated that the
assay could detect down to 0.1% (w/w) levels of GMO [4].
The study concluded that the GMO screening assay was
beneﬁcial in terms of providing a cost-eﬀective screening
method for GM for those laboratories that could not aﬀord
to purchase and maintain high-throughput real-time PCR
capabilities. The “GMO multiplex screen” protocol can be
used as a preliminary screening approach to investigate
samples that may contain GM DNA.
3.2. Generation of DNA Proﬁles. As part of the current study,
theseriesoftestsamplesandpositivecontrolswereevaluated
across the three instruments of the Agilent Bioanalyzer,
the Lab901 TapeStation, and the Shimadzu MultiNA. All
instruments identiﬁed the presence of the correct bands
in the positive controls, and there was no evidence of
contamination in the negative controls. Table 1 shows that
all three instruments were able to correctly identify indi-
vidual PCR amplicons of Zein, Lectin, CaMV, and an NOS
terminator/CaMV 35S promoter complex, which arose from
the proﬁle of the positive control. Within an instrument,
all amplicons were clearly distinguishable from each other.
Whilst the proﬁle from the positive control was consistent
across all three instruments, the estimated size of the
individual amplicons was diﬀerent between instruments.
All three instruments detected the expected amplicons
for the set of six test samples when using the recommended
20ng and 100ng DNA per reaction from the protocol (data
not shown). This result was consistent between all three
instruments and in line with previous results [5]. Therefore,
allthreeinstrumentscouldbeusedtodetectanddiﬀerentiate
between samples containing wild-type maize, GM maize,
wild-type soya, GM soya, and the presence of CaMV viral
DNA.
The positive controls and test samples generally showed
that the lower DNA template concentration (20ng) gave
more reliable results for the presence/absence of amplicons
compared to the higher concentration (100ng), as observed
from previous trials of the protocol on the Agilent Bio-
analyzer 2100 [5]. The NOS terminator and CaMV 35s
promoter amplicons were seen as one peak for all instru-
ments, consistent with the original protocol [4]. Further
optimisation of the GMO screening protocol [4]c o u l db e
aimed at determining if it is possible to resolve these two
closely related peaks, or redesigning of the primers to give
diﬀerent amplicon sizes.
Whilst the individual sizes of the amplicons within the
proﬁle for the positive control diﬀered between instruments,
a consistent DNA proﬁle for the positive control and all
test samples was given across the three instruments. Each
of the instruments could therefore be used to detect and
diﬀerentiate between samples that contain normal and GM
soya, and normal and GM maize, as well as identify the
presenceofCaMVviralDNAthatmaybenaturallyoccurring
with plant and soil samples.
3.3. Evaluation of Performance Characteristics. Having
obtainedthecorrectampliconproﬁlesacrossallthreeinstru-
ments demonstrates the applicability of the three instru-
ments for using the “GMO multiplex screen” protocol, pre-
viously validated on the Agilent Bioanalyzer. A subset of the
data, consisting of the replicate positive controls, was then
used to further characterise the performance characteristics
of precision (repeatability) and bias (trueness) associated
with amplicon sizes across the three instruments. This data
was derived from two replicate runs per instrument, where
each chip/tape within a replicate run contained at least two
positive controls. Because of the diﬀerent sample throughput
associated with the three instruments for analysing the test
samples, only a limited number of reaction wells could be
used for the positive controls to estimate within and between
run variability. For the Bioanalyzer and TapeStation instru-
ments, four replicate positive controls were tested per run
(eight replicates in total), and for the MultiNA, two replicate
positive controls were tested per run (four in total). For each
of the positive control replicates, the estimated size of the
fouramplicons(Zein,Lectin,CaMV,andthecombinedNOS
terminator/CaMV 35S promoter complex) was measured.
This level of replication, which is limited by the throughput
of the instruments, provided a ﬁrst insight into evaluation
of the performance characteristics or trueness and precision
to allow a comparison between the instruments.Biotechnology Research International 5
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Figure 1: Repeatability (%CV) associated with the positive control. Figure 1 shows the precision, expressed as the percentage coeﬃcient
of variation, for each of the four amplicons in the positive controls, per instrument. The values are based on the repeatability both within
and between the two replicate runs for amplicon size. Note: the NOS data consists of the combined NOS terminator/CaMV 35S promoter
complex.
3.4. Precision (Repeatability). Repeatability was calculated
based on the measurement response of estimated base-
pairs (bp) size of each of the amplicons. Repeatability was
expressed as the percentage coeﬃcient of variation (%CV).
Figure 1 shows the repeatability within and between the two
replicate runs per instrument, based on amplicon size.
The Agilent Bioanalyzer 2100 demonstrated the least
within-run variability for estimated amplicon size for all
four amplicons in the positive controls. However, whilst the
between-run repeatability for the Zein and NOS amplicons
was relatively good, the CaMV amplicon had the largest
between-run variability associated with it across all three
instruments.
The Lab901 TapeStation had a larger CV associated with
estimated amplicon size overall, and this was particularly
evident with the CaMV and NOS terminator/CaMV 35s
promoter complex amplicons.
The Shimadzu MultiNa appeared to exhibit relatively
large within-run variation for the Zein and Lectin amplicons
compared to the other two instruments. However, the
between-run variability was very good for the Lectin, CaMV
and the combined NOS terminator/CaMV 35s promoter
complex. In Figure 1, the absence of the repeatability
estimate for the between-run repeatability associated with
the Lectin amplicon does not represent missing data but
indicates that there was no variability between the two
runs in terms of amplicon size (both runs gave an average
estimated amplicon size of 87bp) resulting in a CV of 0%.
Whilst there were minor diﬀerences associated with the
repeatability estimates of the amplicon sizes between the
three instruments, the CV associated with any amplicon
never exceeded 1.75% and 1.98% for the within- and
between-run repeatability estimates, respectively. Therefore,
all three instruments showed good repeatability of the
amplicon sizing within and between chip/tapes and runs
in absolute terms. This further demonstrated the ﬁtness
for purpose of all three instruments in using the “GMO
Multiplex Screen” protocol.
3.5. Bias (Trueness). Table 1 shows the amplicon sizes asso-
ciated with the positive control. The theoretical size refers
to the theoretical number of base pairs associated with each
amplicon based on available DNA sequence information.
This theoretical amplicon size was used as a measure of the
bias (trueness) associated with the results produced by all
three instruments and was calculated across all replicate runs
within the experiment (Figure 2).
Overall, the TapeStation gave estimated amplicon sizes
very close to the theoretical sizes, as shown in Table 1 and
Figure 2. Any observable diﬀerences were well within the
sizing speciﬁcation associated with the instrument.
The MultiNA and Bioanalyzer 2100 overestimated the
theoretical sizes slightly. Overall, the MultiNA demonstrated
less bias than the Bioanalyzer 2100. Whilst the MultiNA
demonstrated some positive bias, the estimated distances
between the four amplicons in the positive control compared
well with the distances separating the four amplicons based
on theoretical size. The Bioanalyzer 2100 demonstrated the
most bias compared with theoretical amplicon sizes, and
the estimated distances between the four amplicons did
not compare as well with the distances separating the four
amplicons based on theoretical size.
However, in absolute terms, the diﬀerences in bias
and amplicon sizing were very small and did not aﬀect6 Biotechnology Research International
−10
−5
0
5
10
20
15
B
i
a
s
(
%
)
Bias from theoretical size
Z
e
i
n
L
e
c
t
i
n
C
a
M
V
N
O
S
Z
e
i
n
L
e
c
t
i
n
C
a
M
V
N
O
S
Z
e
i
n
L
e
c
t
i
n
C
a
M
V
N
O
S
Bioanalyzer TapeStation MultiNA
Figure 2: Bias associated with the amplicons from the positive controls. Figure shows the bias (trueness) associated with the amplicons from
the positive controls, across the three instruments of the Bioanalyzer 2100, TapeStation, and MultiNA. The bias is based on the diﬀerence
between the observed amplicon size per instrument, compared with the theoretical amplicon size based on the sequence information. NOS
represents the combined NOS terminator/CaMV 35s promoter amplicon. Bias is calculated on the measurement response of base pairs (bp).
0
50
100
(
F
U
)
15 80
90
108
131
1500
15 100 200 300 400 1500
(bp)
Figure 3: Electropherogram and “gel-like” image of positive control on the Agilent Bioanalyzer 2100. The x-axis on the electropherogram
represents amplicon size (bp), whist the y-axis represents the measurement response of ﬂuorescence units (FUs). Amplicons of interest in
order of size (bp) are lower marker (15), Zein (80), Lectin (90), CaMV (108) and combined CaMV 35s promoter/NOS terminator (131)
amplicons, and the upper marker (1500).
the interpretation of the DNA proﬁle generated by the
samples. All three instruments were easy to use to correctly
identify the positive controls and test samples.
3.6. Review of Instruments
3.6.1. Agilent Bioanalyzer 2100. Agilent Technologies state
the Bioanalyzer 2100’s advantages to be ease-of-use, speed
of analysis, low sample volumes, and high reproducibility
[9]. This instrument showed the least variability when
repeatedly determining amplicon size, correctly identiﬁed
the amplicons, and was able to quantify their concentration.
This instrument exhibited some small bias in overestimating
amplicon sizes compared to theoretical size. Figure 3 is an
electropherogram and a “gel-like” view of a positive control
sample; both clearly distinguish the amplicons.
3.6.2. Lab901 TapeStation. Lab901 states the TapeStation’s
advantages to be a simple, reliable, and fast DNA elec-
trophoresis [12]. This instrument showed the least bias
results of all instruments when comparing estimated ampli-
con sizes to theoretical sizes and correctly identiﬁed the
amplicons despite being performed using a protocol opti-
mised for the Bioanalyzer 2100. The instrument demon-
strated some variability in terms of amplicon size estimation,
but this was always below a CV of 1.87%. However, at
the stage this study was conducted, the instrument could
not accurately quantify the DNA concentration arising fromBiotechnology Research International 7
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each amplicon. Potential advances in the associated TapeS-
tation Screenplex software may provide opportunities for
automation and data standardisation in terms of operator-
independent multiple amplicon analysis. Figure 4 is an
electropherogram and a “gel-like” view of a positive control;
both clearly distinguish the amplicons.
3.6.3. Shimadzu MCE-202 MultiNA. The manufacturer
states the MCE-202 MultiNA’s advantages to be high-
speed and highly reproducible sample size conﬁrmation
on a reusable microchip [13]. This instrument correctly
identiﬁed and was able to quantify the concentrations of
the amplicons, despite being performed using a protocol
validated on the Bioanalyzer 2100. The instrument exhibits a
veryhighsamplethroughput,allowingupto96samplestobe
analysed on one reusable chip, making it a very cost-eﬃcient
instrument. There was some small bias in overestimating
the amplicon sizes compared to the theoretical amplicon
sizes. Figure 5 is an electrophoregram and a “gel-like”
view of a positive control; both clearly distinguish the
amplicons.
A comparative analysis of the application of the three
alternative electrophoresis instruments of the Agilent Bioan-
alyzer 2100, Lab901 TapeStation, and the Shimadzu MCE-
202 MultiNA was conducted as part of the current study,
showing the ﬁtness for purpose of the “GMO multiplex
screen” protocol across all three instruments. These three
instruments were chosen as a representative cross section of
some of the commercially available electrophoresis systems
currently on the market. Other electrophoresis instruments
are available, and based on the results presented here, it is
likely that the “GMO multiplex screen” protocol will give
good results when applied on these additional instruments.
4. Conclusion
This “GMO multiplex screen” protocol for GMO detection
[4] has been extensively trialled and validated on the Agilent8 Biotechnology Research International
B i o a n a l y z e ra sp a r to fap r e v i o u ss t u d y[ 5], and it was
stated that this approach may provide an alternative route
for detecting GMO ingredients for those laboratories that do
not have access to real-time PCR. Whilst the protocol had
beenvalidatedontheAgilentBioanalyzer,its applicationhad
not been reported or extensively tested on other alternative
electrophoresis instruments.
Overall, all three instruments performed well when
applying the “GMO multiplex screen” protocol and oﬀer
suitablealternativeinstrumentsonwhichtousetheprotocol.
Based on a limited data set, the Agilent Bioanalyzer 2100
appeared the most precise when estimating amplicon size,
both within and between runs, when using the “GMO mul-
tiplex screen” protocol. The Lab901 TapeStation exhibited
the least bias from the theoretical size of the amplicons
using samples evaluated in this study and was the only
technology to correctly size the amplicon in comparison
to their theoretical sizes; both the Bioanalyzer 2100 and
MultiNA instruments tended to overestimate amplicon sizes
slightly compared to the theoretical size. The MultiNA
instrument demonstrated excellent repeatability of most
amplicons between runs. However, the observed bias and
repeatability never exceeded 18% and 2%, respectively.
Whilst there were minor deviations in relation to bias
and precision estimates, all three instruments were able to
correctly detect the presence or absence of the diﬀerent
amplicons and generated the correct characteristic DNA
proﬁles used in this study for a range of test samples and
the positive controls. In this respect, all three instruments
performed ﬁt for purpose in relation to the application of
the “GMO multiplex screen” protocol, and as alternative
instruments, they provide greater scope for analysis of food
authenticity.
The ﬁtness for purpose of a prevalidated “GMO mul-
tiplex screen” protocol was demonstrated as part of a
comparative analysis using just three electrophoresis instru-
ments. The authors emphasise that alternative electrophore-
sis instruments are commercially available that were not
evaluated as part of this study. Based on the evidence
presented here, it is likely that the application of the “GMO
multiplex screen” protocol would give good results across a
range of alternative instruments.
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